Travel Medicine and Infectious Disease
Volume 8, Issue 3 , Pages 176-179 , May 2010

Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: Implications for health policy

  • Masoomeh Sofian

      Affiliations

    • Arak University of Medical Sciences, Arak, Iran
    • ,
  • Arezoo Aghakhani

      Affiliations

    • Clinical Research Dept., Pasteur Institute of Iran, No 69, Pasteur Ave., Tehran 13164, Iran
    • ,
  • Ali-Asghar Farazi

      Affiliations

    • Arak University of Medical Sciences, Arak, Iran
    • ,
  • Mohammad Banifazl

      Affiliations

    • Iranian society for support patients with infectious diseases, Tehran, Iran
    • ,
  • Gelavizh Etemadi

      Affiliations

    • Chamran hospital, Tehran, Iran
    • ,
  • Saeed Azad-Armaki

      Affiliations

    • Khatamolanbia Hospital, Tehran, Iran
    • ,
  • Abolhassan Ziazarifi

      Affiliations

    • Masih Daneshvari hospital, Tehran, Iran
    • ,
  • Zohreh Abhari

      Affiliations

    • Madaen hospital, Tehran, Iran
    • ,
  • Ali Eslamifar

      Affiliations

    • Clinical Research Dept., Pasteur Institute of Iran, No 69, Pasteur Ave., Tehran 13164, Iran
    • ,
  • Akbar Khadem-Sadegh

      Affiliations

    • Clinical Research Dept., Pasteur Institute of Iran, No 69, Pasteur Ave., Tehran 13164, Iran
    • ,
  • Nabiallah Izadi

      Affiliations

    • Iranian Blood Transfusion Organization Research Center, Iran
    • ,
  • Amitis Ramezani

      Affiliations

    • Clinical Research Dept., Pasteur Institute of Iran, No 69, Pasteur Ave., Tehran 13164, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 2166968852; fax: +98 2166465147.

Received 15 November 2009 ,Revised 10 February 2010 ,Accepted 15 February 2010.

References 

  1. Cuthbert JA. Hepatitis A. Old and new. Clin Microb Rev. 2001;14:38–58
  2. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132:1005–1022
  3. World Health Organization (WHO). Department of communicable disease surveillance and response. Hepatitis A. WHO/CDS/CSR/EDC/2000.7.
  4. Foussal MD, Picon C, Sorrentino A. Hepatitis A in childhood. The tip of an infectious disease iceberg. Acta Gastroenterol Latinoam. 2002;32:101–105
  5. Tufenkeji H. Hepatitis A shifting epidemiology in Middle East and Africa. Vaccine. 2000;18:65–67
  6. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008;80(5):833–840
  7. Kaya D, Guler E, Ekerbicer HC, Dilber C, Karabiber H, Guler S, et al. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat. 2007;14(12):830–834
  8. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine. JAMA. 1994;271:1328–1334
  9. Srinivasa Rao AS, Chen MH, Pham BZ, Tricco AC, Gilca V, Duval B, et al. Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. BMC Infect Dis. 2006;6:174
  10. Hepatitis . A vaccines. WHO position paper. Wkly Epidemiol Rec. 2000;75:38–43
  11. Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol. 2009;[Epub ahead of print]
  12. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine. 1992;10:56–58
  13. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine. 2000;18(Suppl. 1):S65–S67
  14. Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Indian J Med Microbiol. 2009;27(1):48–50
  15. Acharya SK, Batra Y, Bhatkal B, Ojha B, Kaur K, Hazari S, et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol. 2003;18(7):822–827
  16. Barzaqua BN. Hepatitis A shifting epidemiology in South-East and China. Vaccine. 2000;(Suppl. 18):S61–S64
  17. Mathur P, Arora NK. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res. 2008;128(6):699–704
  18. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004;19(3):275–278
  19. Saberifiroozi M. Prevention of hepatitis A infection. Hep Mon. 2005;5(1):19–27
  20. Roushan MR, Bijani A, Sagheb R, Jazayeri O. Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. East Mediterr Health J. 2007;13(5):1108–1113

PII: S1477-8939(10)00030-X

doi: 10.1016/j.tmaid.2010.02.004

Travel Medicine and Infectious Disease
Volume 8, Issue 3 , Pages 176-179 , May 2010

Article Tools

* Image Usage & Resolution